Drug Shortage Report for IMITREX
| Report ID | 132304 |
| Drug Identification Number | 02212188 |
| Brand name | IMITREX |
| Common or Proper name | Sumatriptan succinate injection |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 6MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 2x0.5mL (Refill pack / L’emballage de recharge) |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-01-21 |
| Estimated end date | 2021-02-10 |
| Actual end date | 2021-01-27 |
| Shortage status | Resolved |
| Updated date | 2021-01-29 |
| Company comments | |
| Health Canada comments | |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.